Drug · DIN 02231139
THROMBOGEN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 30, 2021.
- Drug Identification Number (DIN)
- 02231139
- Company (DIN owner)
- Johnson & Johnson Medtech, A Division Of Johnson & Johnson (Canada) Inc.Markham, Ontario, Canada
- Schedule
- Schedule D
- Dosage form
- Liquid; Powder
- Route
- Topical
- Therapeutic class (ATC)
- Thrombin B02BC06
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| THROMBIN (BOVINE) | 10000 UNIT | KIT |
| SODIUM CHLORIDE | 10 ML | KIT |
Other DINs named THROMBOGEN
- DIN 02231137 · Cancelled Pre Market
- DIN 02231138 · Cancelled Pre Market
- DIN 02231140 · Cancelled Pre Market